Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Is Not Improving, Rep. Waxman Says: Viagra Ads Show “Six” Sells?

Executive Summary

The decline in advertising enforcement actions by FDA does not reflect better compliance in direct-to-consumer advertisements, House Government Reform Committee Ranking Member Henry Waxman (D-Calif.) maintains

You may also be interested in...



Overactive Bladder Ads Become Frequent; 3 DTC Spots Break In Last 2 Months

Pfizer, Johnson & Johnson and GlaxoSmithKline/ Yamanouchi have each released new direct-to-consumer TV advertisements for their overactive bladder products in the last two months as the sector has become more competitive

Overactive Bladder Ads Become Frequent; 3 DTC Spots Break In Last 2 Months

Pfizer, Johnson & Johnson and GlaxoSmithKline/ Yamanouchi have each released new direct-to-consumer TV advertisements for their overactive bladder products in the last two months as the sector has become more competitive

Rep. Waxman Challenges FDA Contact With Rx Companies On DTC Guides

Rep. Henry Waxman (D-Calif.) is asking FDA to defend its communications with pharmaceutical companies relating to the development of direct-to-consumer advertising guidances

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS040571

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel